Search For

Wen Xie, 52905 Wellesley Ave, Pittsburgh, PA 15206

Wen Xie Phones & Addresses

905 Wellesley Ave, Pittsburgh, PA 15206    412-3620529   

401 Shady Ave, Pittsburgh, PA 15206    412-3620529   

El Monte, CA   

Birmingham, AL   

San Diego, CA   

Baton Rouge, LA   

Cary, NC   

Social networks

Wen Xie

Linkedin

Mentions for Wen Xie

Resumes

Resumes

Wen Xie Photo 1

Wen Xie

Location:
United States

Business Records

Name / TitleCompany / ClassificationPhones & Addresses
Wen Xie
Phd
The University of Pittsburgh 3501 Trc St 566, Pittsburgh, PA 15261
412-3839911
Wen Xie Winfund Investment LLC 18340 Colima Rd, Whittier, CA 91748
12732 Foothill Blvd, Rancho Cucamonga, CA 91739
Wen Xie
Owner
Gene's Cleaners & Laundry 3846 Peck Rd, El Monte, CA 91732
626-4443784
Wen Xie Jv Azalea LLC 17588 Rowland St, Whittier, CA 91748
213 N Citrus Ave, Covina, CA 91723

Publications

Us Patents

Methods Of Treating Estrogen-Responsive Conditions By Orphan Nuclear Receptor Activation

US Patent:
2008008, Apr 10, 2008
Filed:
Aug 29, 2007
Appl. No.:
11/847163
Inventors:
Wen Xie - Pittsburgh PA,
Haibiao Gong - Pittsburgh PA,
Assignee:
University of Pittsburgh - Of the Commonwealth System of Higher Education - Pittsburgh PA
International Classification:
A61K 31/56
A61P 35/00
US Classification:
514182000
Abstract:
The invention provides a method of treating an estrogen responsive condition comprising administration of an agonist of an orphan nuclear receptor, wherein activation of the orphan nuclear receptor inhibits estrogen activity. The invention also provides a method of reducing the size of an estrogen responsive tumor comprising administration of an agonist of an orphan nuclear receptor, wherein activation of the orphan nuclear receptor inhibits estrogen activity. The invention also provides a pharmaceutical composition comprising an agonist of an orphan nuclear receptor and a pharmaceutically acceptable vehicle, wherein activation of the orphan nuclear receptor inhibits estrogen activity.

Constitutive Androstane Receptor (Car) As A Therapeutic Target For Obesity And Type Two Diabetes

US Patent:
2012000, Jan 5, 2012
Filed:
Nov 18, 2009
Appl. No.:
13/129711
Inventors:
Wen Xie - Pittsburgh PA,
Jie Gao - Pittsburgh PA,
Assignee:
UNIVERSITY OF PITTSBURGH-OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION - Pittsburgh PA
International Classification:
A61K 36/282
A61K 31/515
A61K 31/37
A61P 3/10
A61K 31/429
A61K 31/7088
A61K 31/421
A61P 3/04
A61K 31/444
A61K 31/497
US Classification:
424740, 514335, 514270, 514457, 51425505, 514368, 514 44 R, 514374
Abstract:
The invention provides a method of controlling obesity or type two diabetes in a human. In accordance with the inventive method, the constitutive androstane receptor (CAR) is agonized within the human, which effectively controls obesity or type two diabetes.

All data offered is derived from public sources. We do not verify or evaluate each piece of data, and makes no warranties or guarantees about any of the information offered. We do not possess or have access to secure or private financial information. Background Check is not a credit reporting agency and does not offer consumer reports. None of the information offered by Background Check is to be considered for purposes of determining any entity or person's eligibility for credit, insurance, employment, housing, or for any other purposes covered under the FCRA.